Ludwig, M <br/><br/>
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix.  [electronic resource] 

 -  Fertility and sterility  Jan 2001 
 - 18-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(00)01632-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cohort Studies<br/>Congenital Abnormalities--epidemiology<br/>Embryo Transfer<br/>Europe--epidemiology<br/>Female<br/>Fertility Agents, Female--adverse effects<br/>Fertilization in Vitro<br/>Fetal Death--epidemiology<br/>Follow-Up Studies<br/>Germany--epidemiology<br/>Gonadotropin-Releasing Hormone--adverse effects<br/>Health<br/>Hormone Antagonists--adverse effects<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Ovary--drug effects<br/>Pregnancy<br/>Pregnancy Complications--epidemiology<br/>Twins